Full professor
Pharmacy - Direction
Faculty of Pharmacy

Dr. Frédéric Calon is a biochemist-pharmacist affiliated with the Faculty of Pharmacy at Université Laval and has been conducting his research at the CHU de Québec-Université Laval in Quebec City since 2003. His research program focuses on the development of treatments for neurodegenerative diseases. He has extensive expertise with animal models of Alzheimer’s disease (AD) and Parkinson’s disease (PD). He also has longstanding experience in performing cliniconeuropathological studies on human brain samples from individuals with prevalent afflictions such as Essential tremor (ET), AD, and PD. His team has developed a specific niche in investigating the blood-brain barrier and quantifying the transport of various compounds into the brain.

Dr. Calon has published more than 165 peer-reviewed papers cited more than 16,000 times, with an h-index of 69. His work has been extensively covered by various media outlets. He has also contributed to various scientific peer review committees, and his research team is currently funded by various sources, notably CIHR, FRQS, NSERC, CCNA, FRQNT, and JPND.

Finally, Dr. Calon co-leads the Consortium for the Early Identification of Alzheimer’s Disease (CIMA-Q) and the international associated laboratory OptiNutriBrain.

Rationality requires that we distinguish what is true from what we want to be true - S. Pinker